-
A controlled surgical trial of glutamic acid decarboxylase gene therapy, targeting the subthalamic nucleus in advanced Parkinsons's disease, demonstrated statistically significant improvement in motor symptoms off medication in those receiving gene therapy compared with controls.
-
Carbamazepine has been linked with severe forms of hypersensitivity reactions. As such, genome wide approaches to identify patients-at-risk have become increasingly important.
-
A composite score that combines age, motor power, and light touch perception can predict recovery of walking with great accuracy in patients with traumatic spinal cord injury.
-
Seasonal flu and H1N1 vaccines are safe for patients with myasthenia gravis and should be administered.
-
Decompressive craniectomy for severe diffuse traumatic brain injury and refractory intracranial hypertension (ICP) reduces ICP but increases unfavorable outcomes.
-
Rotational vertebral artery syndrome (RVAS) is a rare syndrome usually caused by compression of the dominant vertebral artery in the neck with extreme head rotation to the contralateral side.
-
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
Non-Hodgkin B-cell lymphomas are more likely to be associated with peripheral nerve disorders, and Hodgkin's disease with central nervous system syndromes.
-
Neurosurgical interventions for trigeminal neuralgia have never been rigorously studied for efficacy and carry significant risks.
